SCHEMBL10995451

SCHEMBL10995451

Cc1cc2c(cc1C)OC(C(O)CN1CCN(CC(=O)Nc3ccc(Cl)cc3)CC1)CO2

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.47
ATM Q13315 1/20 0.45
ALDH1A1 P00352 6/20 0.45
TSHR P16473 5/20 0.45
LMNA P02545 2/20 0.45
USP2 O75604 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
CYP2C9 P11712 1/20 0.45
CYP2C19 P33261 1/20 0.45
KCNA5 P22460 2/20 0.45
HTT P42858 2/20 0.43
FPR2 P25090 1/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
KMT2A Q03164 2/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10993684 0.91 ALDH1A1 (0.48) MAPTATMALDH1A1TSHRLMNA
SCHEMBL10991244 0.88 POLB (0.54) MAPTATMALDH1A1TSHRLMNA
SCHEMBL10995111 0.86 LMNA (0.50) MAPTALDH1A1TSHRLMNAUSP2
SCHEMBL10994841 0.85 ALDH1A1 (0.43) MAPTATMALDH1A1TSHRLMNA
SCHEMBL10992935 0.85 CYP3A4 (0.48) ALDH1A1TSHRLMNAUSP2NPSR1
SCHEMBL10990432 0.83 CYP3A4 (0.45) ALDH1A1TSHRLMNAUSP2NPSR1
SCHEMBL10997843 0.83 CYP3A4 (0.45) ALDH1A1TSHRLMNAUSP2NPSR1
SCHEMBL10991908 0.83 RAB9A (0.56) MAPTALDH1A1LMNANPSR1KCNA5
SCHEMBL10996565 0.82 TSHR (0.46) MAPTALDH1A1TSHRLMNAUSP2
SCHEMBL10995044 0.81 ALDH1A1 (0.48) ATMALDH1A1LMNAKCNA5HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4558129-A Benzodioxanyl-hydroxyethylene-piperazinyl acetanilides which effect calcium entry and β-blockade SYNTEX (U.S.A.) INC. (US) 1985-12-10 US disclosed